Výsledky vyhledávání - "Marchelle Meza"

Abstract 2912: INBRX-130, a 5T4-targeted CONTRA-MAB, is a potent CD3 bispecific antibody engineered to have minimal off-tumor activity

Autor: Katelyn M. Willis, Margaret Haerr, Marchelle Meza, Sae Jeong Ahn, Michael Kaplan, Georgina Ortiz-Barquero, Rajay Pandit, Rafael Abalos, Yao Chen, Samuel Holley, Raul Lozano, Iljin Hwang, Emily Rowell, Brendan P. Eckelman

Publikováno v: Cancer Research. 82:2912-2912

Bispecific T cell engagers that target CD3 on T cells and cell-surface antigens on tumor cells have demonstrated meaningful clinical activity against hematological cancers but have yet to achieve similar efficacy for the treatment of solid tumors. A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7c0eba979f2dffd51b481d0dcfbc452
https://doi.org/10.1158/1538-7445.am2022-2912

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání